Emcure Pharmaceuticals public issue witnessed a lukewarm start on the first day of bidding on July 3, led by non-institutional and retail investors. The company's Rs 1,952.03-crore public offer was subscribed 0.29 times so far, receiving bids for 39.06 lakh shares as against 73.07 crore shares on offer, the subscription data on the exchanges showed.